Cat.#: ACPP-1674
| Despition | KCNIP3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1714 | Human PGR Protein (AC1714) | 2 µg | inquiry |
| ACPP-1309 | CCR5 Blocking Peptide (AC1309) | 250 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
| ACPP-1100 | Synthetic Membrane Nanoparticle Human Somatostatin Receptor 2 Protein (AC1100) | 50 µg | inquiry |
| ACPP-1186 | Olig2 Blocking Peptide (AC1186) | 250 µg | inquiry |
| ACPP-1406 | Human Recoverin Protein (AC1406) | 10 µg | inquiry |
| ACPP-1265 | EDG8 Blocking Peptide (AC1265) | 250 µg | inquiry |
| ACPP-1703 | Human PITPNA Protein (AC1703) | 5 µg | inquiry |
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1360 | Human GAD65 Protein (AC1360) | 1 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.